Literature DB >> 8427049

Cytokine production and surface antigen expression by peripheral blood mononuclear cells in postmenopausal osteoporosis.

F G Hustmyer1, E Walker, X P Yu, G Girasole, Y Sakagami, M Peacock, S C Manolagas.   

Abstract

It was reported earlier that IL-1 production by cultured monocytes and the ratio of helper (CD4) to suppressor (CD8) lymphocytes in peripheral blood are different in osteoporotic compared to nonosteoporotic subjects. We examined these and several other parameters related to the biosynthetic activity and differentiation status of peripheral blood mononuclear cells (PBMC) in untreated osteoporotic postmenopausal women (age 65 +/- 7, n = 46), nonosteoporotic postmenopausal women (age 55 +/- 3, n = 20), and nonosteoporotic premenopausal women (age 37 +/- 7, n = 8), as defined by spine density. We found that unstimulated monocytes from osteoporotics did not produce detectable IL-1 beta as determined by ELISA. In addition, there were no significant differences between osteoporotics and nonosteoporotics in IL-1 beta or IFN-gamma production by PBMC stimulated with OKT3, a monoclonal antibody to the T cell-receptor complex. The proliferative response of lymphocytes to OKT3 was significantly less (p < 0.02) in osteoporotics compared to nonosteoporotic post- and premenopausal women; multiple-regression analysis, however, indicated that this difference was not due to bone density but to age. Flow cytometric analysis of PBMC revealed no difference between osteoporotics and nonosteoporotics in the distribution of 18 phenotypic subsets determined, including CD4- or CD8-positive lymphocytes or the ratio of CD4 to CD8 cells. Further, there was no correlation of the surface markers with bone density, the exceptions being the subsets expressing the CD3/CD56 and CD8/CD56 markers, which were inversely related to spine density in the osteoporotic women.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8427049     DOI: 10.1002/jbmr.5650080108

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  11 in total

Review 1.  Proinflammatory cytokines and osteoporosis.

Authors:  Robert R McLean
Journal:  Curr Osteoporos Rep       Date:  2009-12       Impact factor: 5.096

2.  Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor.

Authors:  N J Horwood; N Udagawa; J Elliott; D Grail; H Okamura; M Kurimoto; A R Dunn; T Martin; M T Gillespie
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

3.  Cytokine production by whole blood cells: relationship to interleukin gene polymorphism and bone mass.

Authors:  Jung Gu Kim; Seung Yup Ku; Kyung Sil Lim; Byung Chul Jee; Chang Suk Suh; Seok Hyun Kim; Young Min Choi; Shin Yong Moon
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

4.  Association of interleukin-1 beta (-511C/T) polymorphisms with osteoporosis in postmenopausal women.

Authors:  Tai-Hung Chao; Hsing-Ning Yu; Chi-Chuan Huang; Wen-Shen Liu; Ya-Wen Tsai; Wen-Tung Wu
Journal:  Ann Saudi Med       Date:  2010 Nov-Dec       Impact factor: 1.526

5.  Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor.

Authors:  T Bellido; R L Jilka; B F Boyce; G Girasole; H Broxmeyer; S A Dalrymple; R Murray; S C Manolagas
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

6.  Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice.

Authors:  R Kitazawa; R B Kimble; J L Vannice; V T Kung; R Pacifici
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

7.  The effect of risedronate treatment on serum cytokines in postmenopausal osteoporosis: a 6-month randomized and controlled study.

Authors:  Umit Dundar; Vural Kavuncu; Ihsan H Ciftci; Deniz Evcik; Ozlem Solak; Tuncay Cakir
Journal:  J Bone Miner Metab       Date:  2009-03-20       Impact factor: 2.626

8.  Inflammatory markers and bone health in postmenopausal women: a cross-sectional overview.

Authors:  Bolaji Lilian Ilesanmi-Oyelere; Linda Schollum; Barbara Kuhn-Sherlock; Michelle McConnell; Sonya Mros; Jane Coad; Nicole C Roy; Marlena Cathorina Kruger
Journal:  Immun Ageing       Date:  2019-07-10       Impact factor: 6.400

Review 9.  Interferon-Gamma-Mediated Osteoimmunology.

Authors:  Mengjia Tang; Li Tian; Guojing Luo; Xijie Yu
Journal:  Front Immunol       Date:  2018-06-29       Impact factor: 7.561

Review 10.  Updates on Osteoimmunology: What's New on the Cross-Talk Between Bone and Immune System.

Authors:  Marco Ponzetti; Nadia Rucci
Journal:  Front Endocrinol (Lausanne)       Date:  2019-04-18       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.